CIK 0000921114 · Non-accelerated filer<br>Smaller reporting company
Armata Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ARMP
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 911549568
- Phone
- 310-665-2928
- Business address
- 5005 MCCONNELL AVE, LOS ANGELES, CA, 90066
- Former names
- AmpliPhi Biosciences Corp, TARGETED GENETICS CORP /WA/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-05 | Kyme Pierre Chief Business Officer | Grant or award · Stock Options (Right to Buy) | +100,000 | 100,000 | ||
| 2025-02-05 | Kramer Robin Director | Grant or award · Stock Options (Right to Buy) | +54,343 | 54,343 | ||
| 2025-02-05 | House David Duane SVP, Finance, and PFO | Grant or award · Stock Options (Right to Buy) | +25,000 | 25,000 | ||
| 2025-02-05 | Haimovitz Jules Director | Grant or award · Stock Options (Right to Buy) | +54,343 | 54,343 | ||
| 2025-02-05 | Birx Deborah Chief Executive Officer | Grant or award · Stock Options (Right to Buy) | +240,000 | 240,000 | ||
| 2024-10-02 | House David Duane SVP, Finance, and PFO | Grant or award · Stock Options (Right to Buy) | +75,000 | 75,000 | ||
| 2024-07-10 | Birx Deborah Chief Executive Officer | Shares withheld for taxes | −22,925 | $2.68 | $61K | 237,075 |
| 2024-03-14 | PATTI JOSEPH M Director | Grant or award · Stock Options (Right to Buy) | +39,666 | 39,666 | ||
| 2024-03-14 | PATTI JOSEPH M Director | Grant or award · Stock Options (Right to Buy) | +54,343 | 94,009 | ||
| 2024-03-14 | Kramer Robin Director | Grant or award · Stock Options (Right to Buy) | +39,666 | 39,666 | ||
| 2024-03-14 | Kramer Robin Director | Grant or award · Stock Options (Right to Buy) | +54,343 | 94,009 | ||
| 2024-03-14 | Peterson Todd C. Director | Grant or award · Stock Options (Right to Buy) | +39,666 | 39,666 | ||
| 2024-03-14 | Peterson Todd C. Director | Grant or award · Stock Options (Right to Buy) | +54,343 | 94,009 | ||
| 2024-03-14 | Rychlik Richard Corporate Controller and PFO | Grant or award | +10,000 | 10,000 | ||
| 2024-03-14 | Rychlik Richard Corporate Controller and PFO | Grant or award · Stock Options (Right to Buy) | +40,000 | 40,000 | ||
| 2024-03-14 | Schlesinger Sarah J. Director | Grant or award · Stock Options (Right to Buy) | +39,666 | 39,666 | ||
| 2024-03-14 | Schlesinger Sarah J. Director | Grant or award · Stock Options (Right to Buy) | +54,343 | 94,009 | ||
| 2024-03-14 | Haimovitz Jules Director | Grant or award · Stock Options (Right to Buy) | +39,666 | 39,666 | ||
| 2024-03-14 | Haimovitz Jules Director | Grant or award · Stock Options (Right to Buy) | +54,343 | 94,009 | ||
| 2024-03-14 | Odysseas Kostas D Director | Grant or award · Stock Options (Right to Buy) | +39,666 | 39,666 |
Page 2 of 7 · 122 trades